341/435US=35 / Câncer
Steensma DP. Molecular foundations of AML pathogenesis and physiology: the DNA damage response, DNA repair, and AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 97-131. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOGENA AGUDA; RESPOSTA DE DANO DO DNA; REPARO DE DNA; RECONHECIMENTO DOS DANOS DO DNA; REPARO POR EXCISAO DE BASE; REPARO POR EXCISAO DE NUCLEOTIDEOS; RECOMBINACAO HOMOLOGA; ANEMIA DE FANCONI; SINDROME DE BLOOM; FAMILIA RECQ HELICASES; SINDROMES HEREDITARIAS; ATAXIA-TELANGIECTASIA; SINDROME DE QUEBRA DE NIJMEGEN; SINDROME DE SECKEL; PROTEINA NIBRIN

342/435US=35 / Câncer
Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4.

LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3

343/435US=35 / Câncer
Ross DD. Molecular foundations of AML pathogenesis and physiology: drug resistance transporters in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 163-73. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOGENA AGUDA; TRANSPORTADORES DE RESISTENCIA DE DROGAS

344/435US=35 / Câncer
Grimwade D. Translating biology into clinical application: impact of cytogenetics on clinical outcome in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 177-92. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOGENA AGUDA; BIOLOGIA; APLICACAO CLINICA; CITOGENETICA; REARRANJOS CROMOSSOMICOS CRIPTICOS; HIBRIDACAO IN SITU FLUORESCENTE; TRIAGEM MOLECULAR; ESTRATIFICACAO DE RISCO; DISSOMIA UNIPARENTAL ADQUIRIDA

345/435US=35 / Câncer
Frankfurt O, Peterson LC, Gallagher R, Tallman MS. Translating biology into clinical application: APL: a classic tale of bench to bedside. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 193-228. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE AGUDA; PML-RARALFA; COAGULOPATIA; ACIDO RETINOICO; TRIOXIDO ARSENICO; SINDROME DO ACIDO RETINOICO

346/435US=35 / Câncer
Sausville EA. Molecular therapeutics of AML: selected targeted approaches: emerging therapeutics for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 231-46. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; EMERGENCIAS TERAPEUTICAS; NOVOS AGENTES; TERAPIA ALVO; VACINA; SINALIZACAO VEGF; ADAFOSTINA; TRITERPENOIDES

347/435US=35 / Câncer
Levis M. Molecular therapeutics of AML: FLT3: a prototype receptor tyrosine kinase target in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 247-61. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; QUINASE; FLT3; PROGNOSTICO; INIBIDORES; CELULAS TRONCO

348/435US=35 / Câncer
Lancet JE. Molecular therapeutics of AML: farnesyl transferase inhibitors in the therapy of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 263-74. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; FARNESILACAO; INIBIDORES DE FARNESITRANSFERASE; TRANSDUCAO DE SINAL

349/435US=35 / Câncer
Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA

350/435US=35 / Câncer
Lin TL, Matsui W. Molecular therapeutics of AML: differentiation therapy in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 293-312. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; TERAPIA DIFERENCIADA; SINDROME MIELODISPLASICA; FATORES DE CRESCIMENTO; CICLO CELULAR; ACIDO RETINOICO; VITAMINA D; METILACAO DO DNA; BRIOSTATINA 1

351/435US=35 / Câncer
Bolaños-Meade J, Jones RJ. Molecular therapeutics of AML: stem cell transplantation for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 313-27. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; TRANSPLANTE DE CELULAS TRONCO; SINDROME MIELODISPLASICA; LEUCEMIA PROMIELOCITICA; TRANSPLANTE DE MEDULA OSSEA; DOENCA ENXERTO VERSUS HOSPEDEIRO

352/435US=35 / Câncer
Borrello I. Molecular therapeutics of AML: tumor vaccines in leukemia. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 329-41. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; VACINA

353/435US=35 / Câncer
Arceci RJ. Special challenges: treatment, outcomes, and challenges of newly diagnosed AML in children and adolescents. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 345-72. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; CRIANCA; ADOLESCENTE; PREDISPOSICAO HEREDITARIA; SINDROMES FAMILIARES; INSTABILIDADE CROMOSSOMICA; METABOLISMO DA DROGA; ESTRATIFICACAO DO GRUPO DE RISCO

354/435US=35 / Câncer
Stone RM. Special challenges: AML in older adults. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 373-84. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; ADULTO; LEUCEMIA MIELOIDE AGUDA. DIAGNOSTICO; LEUCEMIA MIELOIDE AGUDA. CLASSIFICACAO; LEUCEMIA MIELOIDE AGUDA. PROGNOSTICO; LEUCEMIA MIELOIDE AGUDA. TRATAMENTO

355/435US=35 / Câncer
Gotlib J. Special challenges: dameshek smiles: molecular clues to the chronic myeloproliferative disorders unmasked. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 385-98. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; DOENCAS REUMATICAS CRONICAS; JAK2 V617F; POLICITEMIA VERA; TROMBOCITEMIA ESSENCIAL; MIELOFIBROSE IDIOPATICA; DOENCA MIELOPROLIFERATIVA

356/435US=35 / Câncer
Estey E. Special challenges: new designs for clinical trials. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 399-415. (Contemporary Hematology) ISBN 978-1-58829-621-4.

LEUCEMIA MIELOIDE AGUDA; ENSAIOS CLINICOS; 3 PROJETO 3; MODELOS DE DUAS FASES CONVENCIONAIS; METODOLOGIA BAYESIANA

357/435US=49 / Câncer
Ringdén O. Immunotherapy by allogeneic stem cell transplantation. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 25-60. ISBN 978-0-12-006697-1.

IMUNOTERAPIA; TRANSPLANTE DE CELULAS-TRONCO ALOGENICO; DOENCA DO ENXERTO-VERSUS-HOSPEDEIRO; ENXERTO-VERSUS-LEUCEMIA; CELULAS NK; ENXERTO CONTRA O CANCER; CELULAS-TRONCO MESENQUIMAIS

358/435US=77-J / Câncer
Oliveira MBR, Gomes GF, Dellamano M. Alterações cromossômicas em câncer. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 38-43. ISBN 8-5866523-7-0.

CANCER; ABERRACOES CROMOSSOMICAS; ALTERACOES CROMOSSOMICAS; LEUCEMIA; LINFOMA; TUMORES SOLIDOS

359/435US=49-B / Câncer
Hu J, Zhou GB, Wang ZY, Chen SJ, Chen Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 191-220. ISBN 978-0-12-373896-7.

FATORES DE TRANSCRICAO MUTANTES; TIROSINA QUINASES; LEUCEMIAS; LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE CRONICA

360/435US=77-J / Câncer
Chojniak MM, Kikawa MH. Câncer oftalmológico. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 383-9. ISBN 8-5866523-7-0.

CANCER DE OLHO; TUMORES INTRAOCULARES; MELANOMA MALIGNO DA UVEA; HEMANGIOMA DA COROIDE; OSTEOMA DA COROIDE; CARCINOMA METASTATICO DA COROIDE; HIPERPLASIA LINFOIDE REATIVA; LINFOMA NAO HODGKIN; TUMORES DE CELULAS GIGANTES; LEUCEMIA; TUMORES DA CONJUNTIVA; CARCINOMA DE CELULAS ESCAMOSAS; MELANOMA DE CONJUNTIVA; TUMORES LINFOIDES DA CONJUNTIVA; TUMORES MALIGNOS DA PALPEBRA; TUMORES DA GLANDULA LACRIMAL

Primeira | Anterior | Próxima | Última